Edition:
United Kingdom

Erytech Pharma SA (ERYP.OQ)

ERYP.OQ on NASDAQ Stock Exchange Global Select Market

19.85USD
22 May 2018
Change (% chg)

-- (--)
Prev Close
$19.85
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
509
52-wk High
$30.48
52-wk Low
$17.50

Chart for

About

Erytech Pharma SA, also known as ERYTECH Pharma, is a France-based biopharmaceutical company developing medicinal products mainly in oncology, hematology and immunology fields of business. The Company offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The... (more)

Overall

No Ratios Available.

Financials

  ERYP.OQ Industry Sector
P/E (TTM): -- 237.88 32.90
EPS (TTM): -- -- --
ROI: -- -7.38 12.74
ROE: -- -10.11 14.64

BRIEF-Erytech To Present Results From Phase I Trial Of Eryaspase In All And New Pre Clinical Data At Aacr 2018

* ERYTECH TO PRESENT RESULTS FROM PHASE I TRIAL OF ERYASPASE IN ALL AND NEW PRE-CLINICAL DATA AT AACR 2018 Source text for Eikon: Further company coverage:

12 Apr 2018

BRIEF-Oncodesign Concludes A Partnership With Erytech In Oncology

* ONCODESIGN CONCLUDES A LONG TERM SERVICE-BASED PARTNERSHIP WITH ERYTECH IN ONCOLOGY

27 Mar 2018

BRIEF-Erytech FY Net Loss Widens To 33.5 Million Euros

* REPORTED ON MONDAY FY NET LOSS 33.5 MILLION EUROS, COMPARED TO 21.9 MILLION EUROS IN 2016

13 Mar 2018

Earnings vs. Estimates